Notify me when ARDSLEY ADVISORY PARTNERS LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ASBP | Aspire Biopharma Holdings, Inc. | Common Stock | 7.8% | $860,000 | 10,750,000 | Ardsley Advisory Partners LP | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|